Search

Byline: James Warrington MEDICAL companies are ditching the UK for clinical research in favour of other countries after an intense focus on Covid treatment crowded out other projects, according to [...]

Byline: Iain Withers THE UK's top pharmaceutical firms have warned MPs that a hard Brexit could cause 'significant disruption' to the supply of medicines to patients. FTSE 100 drugmaker AstraZeneca [...]

Byline: Iain Withers Late last year Britain's competition watchdog slapped a record PS90m worth of fines on US drugs giant Pfizer, and British manufacturer Flynn, for jacking up the price [...]

Byline: Iain Withers A JUDICIAL review challenge mounted by big pharmaceutical companies against NHS drug pricing powers has been thrown out by the High Court. The Association of the British [...]

Byline: Iain Withers With NHS budgets under pressure and medicine prices inexorably going up, something had to give. Nevertheless, the decision by some of the world's largest pharmaceutical firms this [...]

Byline: Iain Withers THE NHS has accused big pharmaceutical firms of making spurious arguments to mount a High Court challenge to drug pricing powers designed to keep a lid on [...]

Byline: Iain Withers BRITISH patients unable to obtain the life-saving drugs they rely on because they are manufactured on the Continent. Lorries loaded with tens of thousands of live medicine [...]

Byline: Iain Withers THE European Union's drugs regulator has admitted Brexit guidance issued last week that experts warned could cost the UK pharma sector hundreds of millions of pounds to [...]

Byline: Iain Withers THE UK pharmaceuticals sector has been told to prepare for a 'crisis' Brexit scenario of drastically reduced access to European markets and hundreds of millions of pounds [...]

Patients could access new medicines up to 6 months earlier in a deal expected to save the NHS around 930 million next year.The government and the Association of the British [...]

The future of the NHS will be among the defining issues of this year's general election campaign. Join us on 11 March in London at our free Big Health Debate [...]

Byline: Sarah Boseley Roche, the Swiss pharmaceutical company at the centre of the row over cancer drugs pricing, played a significant part in the genesis of the Cancer Drugs Fund, [...]

Byline: Sarah Boseley, Health editor Drug companies are paying an estimated pounds 40m a year to British doctors in service fees, flights, hotel and other travel expenses, according to the [...]

Research and development expenditure on pharmaceuticals dipped in 2003 and capital investment fell more sharply, the Association of the British Pharmaceutical Industry said yesterday. Britain's trade balance in pharmaceuticals also [...]

LONDON -- Researchers and leading medical journals yesterday gave a cautious welcome to plans unveiled by the pharmaceutical industry to publish more data on the clinical trials of new medicines. [...]

The Association of the British Pharmaceutical Industry (ABPI) named Ivan Dennie as its events manager. Dennie took up the post on September 16. He arrives from the pharmaceuticals company Roche. [...]

Pfizer, the US pharma-ceuticals group, has been given a rare public reprimand by the industry body in the UK for promoting a drug that had not been approved. The Association [...]

TREVOR Jones, director-general of the pharmaceutical industry's trade body, said yesterday that Royal Bank of Scotland had failed to give an assurance that it would back companies in the sector [...]

Some drug companies may refuse to co-operate with the National Institute for Clinical Excellence if it goes ahead with plans to publish its provisional determinations on drugs, it was claimed [...]

Pharmaceutical companies may stop using the UK for the first launch of new medicines, the Association of the British Pharmaceutical Industry warned yesterday after the National Institute of Clinical Excellence [...]

Sir: Having just returned from medical work in Nepal, I am intrigued by the Association of the British Pharmaceutical Industry's statement that 'the pharmaceutical industry in the UK is highly [...]

R&D Trends [??] * BioPontis Alliance for Rare Diseases, an international nonprofit organization, and VIB, an excellence-based life science research institute in Belgium, announced a strategic partnership in rare diseases. [...]

Selection of cases before the EU Court of Justice and General Court from 19 to 23 April Thursday 22 April - Judgement in Case C-62/09 Association of the British Pharmaceutical [...]

The pharma industry in the U.K. is turning to the courts to prevent a new 'budget impact' test from being used to bring down drug prices. The test, introduced on [...]

Astellas UK's suspension as a member of the Association of the British Pharmaceutical Industry (ABPI) is to be extended for a further 12 months effective June 24 in connection with [...]

2004 JUL 19 - (NewsRx.com & NewsRx.net) -- Clinical trials in Britain will receive a major boost from the creation of the U.K. Clinical Research Collaboration (UKCRC), the Association of [...]

* Researchers in the U.K. still reeling from the Brexit vote have been told by the science minister Jo Johnson to carry on as before. 'We remain an EU member [...]

* With the number of biosimilars approved in Europe on the rise, the U.K. Bioindustry Association (BIA) and the Association of the British Pharmaceutical Industry (ABPI) have joined forces in [...]

The Association of the British Pharmaceutical Industry (ABPI) has established a new Inward Investor Group to demonstrate the importance of inward investment to the U.K. and the global mobility of [...]